A PSP-like phenotype accompanies rapidly progressive dementia
Objective: We describe a patient with a progressive supranuclear palsy (PSP)-like phenotype and a rapidly progressive dementia, who was found to have an unknown CSF…Tongue Strength in PSP
Objective: To describe anterior and posterior tongue elevation strength in participants with PSP Background: It is widely recognized that the tongue plays a critical role…Use of the Neuropsychiatric Inventory to Characterize the Course of Neuropsychiatric Symptoms in Progressive Supranuclear Palsy
Objective: The aim of this study was to determine the neuropsychiatric profile in our cohort of PSP patients and their dynamic changes over a follow-up…Effect of low frequency stimulation on freezing of gait in a PSP patient with bilateral STN DBS
Objective: To study the effect of low frequency stimulation (LFS) on freezing of gait (FOG) in a progressive supranuclear palsy (PSP) patient with bilateral STN…REM sleep behavior disorder: Is it useful to differentiate between Parkinson disease and Progressive Supranuclear Palsy?
Objective: To determine the prevalence of rapid eye movement (REM) sleep behavior disorder (RBD) in autopsy confirmed Parkinson disease (PD) and Progressive Supranuclear Palsy (PSP).…Dysphagia in PSP
Objective: To characterize the nature of dysphagia accompanying progressive supranuclear palsy (PSP). Background: Dysphagia is a frequent symptom of PSP, typically occurring early in the…Levodopa induced dyskinesia in a case of progressive supranuclear palsy.
Objective: We describe the mechanism of dyskinesia in patients with progressive supranuclear palsy (PSP). Background: Levodopa generally shows a poor effect to parkinsonism in patients…Tyrosine kinase inhibition clears Tau and reserves neuropathology and motor symptoms in a novel model of progressive supranuclear palsy
Objective: Our objective was to examine the effects of tau accumulation in transgenic mice, observing both motor function and behavior. Background: Tau hyper-phosphorylation is a…Manual MRI morphometry in Parkinsonian syndromes
Objective: We investigated a large sample of Parkinsonian patients and healthy controls from five German academic medical centers with 3D MP-RAGE sequences on mainly 3T…Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease
Objective: To evaluate the differences in striatal subregional dopamine transporter loss in Parkinson's disease (PD) and supranuclear palsy (PSP) and the diagnostic value of [18F]PR04.MZ…
- « Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 42
- Next Page »